(19)
(11) EP 0 832 295 A1

(12)

(43) Date of publication:
01.04.1998 Bulletin 1998/14

(21) Application number: 96921406.0

(22) Date of filing: 06.06.1996
(51) International Patent Classification (IPC): 
C07K 14/ 51( . )
C12N 15/ 12( . )
G01N 33/ 50( . )
C07K 14/ 71( . )
C12Q 1/ 68( . )
G01N 33/ 567( . )
(86) International application number:
PCT/US1996/009638
(87) International publication number:
WO 1996/041013 (19.12.1996 Gazette 1997/03)
(84) Designated Contracting States:
CH DE FR GB IT LI NL

(30) Priority: 07.06.1995 US 19950482436

(71) Applicant: LIGAND PHARMACEUTICALS INCORPORATED
San Diego, California 92121 (US)

(72) Inventors:
  • McDONNELL, Donald P.
    San Diego, CA 92131 (US)
  • DELORME, Evelyn
    San Diego, CA 92122 (US)
  • MINER, Jeffrey N.
    San Diego, CA 92122 (US)
  • GLEESON, Martin A.G.
    San Diego, CA 92130 (US)
  • WEN, Xiaohong Dawn
    San Diego, CA 92122 (US)
  • PIKE, J.Wesley
    Encinitas, CA 92024 (US)

(74) Representative: Viering, Jentschura & Partner 
Postfach 22 14 43
80504 München
80504 München (DE)

   


(54) METHOD FOR SCREENING FOR RECEPTOR AGONISTS AND ANTAGONISTS